Fluticasone-Salmeterol Drug Combination
"Fluticasone-Salmeterol Drug Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
| Descriptor ID |
D000068297
|
| MeSH Number(s) |
D02.033.100.291.057.750.500 D02.092.063.291.057.750.500 D02.092.471.683.061.750.500 D04.210.500.054.079.129.114.500 D26.310.438
|
| Concept/Terms |
Fluticasone-Salmeterol Drug Combination- Fluticasone-Salmeterol Drug Combination
- Drug Combination, Fluticasone-Salmeterol
- Fluticasone Salmeterol Drug Combination
- Fluticasone - Salmeterol
- Fluticasone Salmeterol
- Fluticasone-Salmeterol Combination
- Combination, Fluticasone-Salmeterol
- Fluticasone Salmeterol Combination
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination- Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
- Fluticasone Propionate-Salmeterol Xinafoate Combination
- Fluticasone Propionate Salmeterol Xinafoate Combination
- Fluticasone Propionate-Salmeterol Drug Combination
- Fluticasone Propionate Salmeterol Drug Combination
- Fluticasone Propionate - Salmeterol Combination
- Fluticasone Propionate Salmeterol Combination
- Fluticasone Propionate-Salmeterol Xinafoate Drug Combination
- Fluticasone Propionate Salmeterol Xinafoate Drug Combination
- Fluticasone Propionate - Salmeterol Xinafoate
- Fluticasone Propionate Salmeterol Xinafoate
- Fluticasone Propionate - Salmeterol
- Fluticasone Propionate Salmeterol
|
Below are MeSH descriptors whose meaning is more general than "Fluticasone-Salmeterol Drug Combination".
Below are MeSH descriptors whose meaning is more specific than "Fluticasone-Salmeterol Drug Combination".
This graph shows the total number of publications written about "Fluticasone-Salmeterol Drug Combination" by people in this website by year, and whether "Fluticasone-Salmeterol Drug Combination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 2 | 2 |
| 2011 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fluticasone-Salmeterol Drug Combination" by people in Profiles.
-
Controversies in Allergy: Should Severe Asthma with Eosinophilic Phenotype Always Be Treated with Anti-IL-5 Therapies. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1430-1436.
-
Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting ?2-agonist fixed-dose combination: RE(2)SPOND rationale and study design. Int J Chron Obstruct Pulmon Dis. 2016; 11:1921-8.
-
A 15-year-old boy with severe combined immunodeficiency, fungal infection, and weight gain. Allergy Asthma Proc. 2015 Sep-Oct; 36(5):407-11.
-
Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients. Respir Med. 2014 Aug; 108(8):1171-9.
-
Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD. Respir Med. 2012 Jan; 106(1):91-101.
-
Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD. Respir Med. 2011 Sep; 105(9):1322-30.
-
The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study. Clin Ther. 2005 May; 27(5):531-42.
-
The bronchodilator response to salmeterol is maintained with regular, long-term use in patients with COPD. Pulm Pharmacol Ther. 2005; 18(1):19-22.